Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

VISTA CLINICAL DIAGNOSTICS LLC

NPI: 1780001859 · DANVILLE, VA 24540 · Clinical Medical Laboratory · NPI assigned 03/26/2014

$3.34M
Total Medicaid Paid
810,309
Total Claims
543,869
Beneficiaries
90
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialOWEN, PATRICIA (EX DIRECTOR OF ADMINISTRATION)
NPI Enumeration Date03/26/2014

Related Entities

Other providers sharing the same authorized official: OWEN, PATRICIA

ProviderCityStateTotal Paid
ACCESS DERMPATH INC BOCA RATON FL $126K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 64,623 $135K
2019 84,066 $224K
2020 101,860 $637K
2021 105,807 $668K
2022 114,182 $537K
2023 159,509 $593K
2024 180,262 $551K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 14,362 6,890 $674K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 155,709 86,702 $607K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 82,289 56,993 $266K
80053 Comprehensive metabolic panel 55,520 41,190 $204K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 13,021 11,475 $157K
80048 Basic metabolic panel (calcium, ionized) 49,834 33,198 $157K
84443 Thyroid stimulating hormone (TSH) 22,874 19,990 $124K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 7,562 3,977 $109K
80061 Lipid panel 17,587 15,774 $104K
83036 Hemoglobin; glycosylated (A1C) 26,192 23,323 $103K
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) 66,902 37,567 $86K
83880 4,070 3,016 $54K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 516 415 $49K
87086 Culture, bacterial; quantitative colony count, urine 20,312 17,074 $49K
82607 7,251 6,222 $46K
80164 5,732 4,842 $39K
36415 Collection of venous blood by venipuncture 98,379 55,051 $33K
87186 10,091 8,891 $30K
82746 5,320 4,546 $30K
83735 11,171 8,733 $29K
87077 10,731 8,451 $27K
82140 3,706 2,323 $27K
85027 13,442 10,084 $26K
80177 4,004 3,298 $25K
86141 3,957 2,137 $24K
81001 22,157 18,694 $21K
85610 12,254 3,495 $18K
82728 2,884 2,525 $17K
87631 473 394 $16K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,437 1,133 $16K
83550 3,504 3,089 $13K
82652 1,322 1,119 $13K
80202 2,622 746 $13K
80076 3,053 2,623 $12K
83540 4,032 3,531 $12K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 285 265 $9K
87070 2,709 2,185 $8K
87493 926 840 $8K
85651 4,599 2,631 $8K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 511 455 $8K
83721 1,673 1,526 $8K
83970 423 378 $6K
80185 1,296 926 $6K
84439 1,656 1,437 $6K
84436 2,250 2,034 $4K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 72 70 $4K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 12,011 7,551 $4K
87205 2,264 1,825 $4K
84153 527 458 $3K
84550 1,830 1,606 $3K
82248 994 899 $2K
87088 1,035 874 $2K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 36 29 $2K
80069 832 690 $2K
80050 General health panel 218 173 $2K
84479 1,205 1,079 $2K
82550 666 369 $2K
84100 1,130 856 $2K
87147 937 797 $2K
84134 250 214 $1K
82565 540 316 $1K
85379 173 110 $1K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 19 12 $1K
85044 508 461 $995.33
85014 1,251 868 $857.17
85018 1,250 865 $848.84
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 56 31 $785.36
82977 484 427 $681.40
83690 295 250 $508.82
82274 109 100 $491.39
80074 19 15 $454.12
84145 55 36 $451.84
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 178 81 $345.14
87040 118 65 $245.29
80184 58 50 $234.56
80305 37 28 $219.25
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 15 14 $206.45
82610 33 29 $195.86
82570 136 124 $176.03
84480 30 25 $150.10
84132 141 108 $148.55
86803 13 12 $128.72
80156 30 27 $116.27
80178 30 25 $110.30
87449 12 12 $98.24
87505 18 12 $88.67
86403 38 38 $76.51
82043 26 25 $37.09
82150 13 13 $35.60
82040 17 12 $17.29